Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alx Oncology Holdings (ALXO) Interest & Investment Income (2020 - 2026)

Alx Oncology Holdings' Interest & Investment Income history spans 4 years, with the latest figure at $3.0 million for Q4 2023.

  • On a quarterly basis, Interest & Investment Income rose 65.74% to $3.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $10.6 million, a 148.92% increase, with the full-year FY2025 number at $4.0 million, down 57.68% from a year prior.
  • Interest & Investment Income hit $3.0 million in Q4 2023 for Alx Oncology Holdings, up from $2.7 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for ALXO hit a ceiling of $3.0 million in Q4 2023 and a floor of -$226000.0 in Q3 2020.
  • Historically, Interest & Investment Income has averaged $946375.0 across 4 years, with a median of $504500.0 in 2020.
  • Biggest five-year swings in Interest & Investment Income: tumbled 97.32% in 2021 and later soared 8504.76% in 2022.
  • Tracing ALXO's Interest & Investment Income over 4 years: stood at $784000.0 in 2020, then tumbled by 97.32% to $21000.0 in 2021, then soared by 8504.76% to $1.8 million in 2022, then surged by 65.74% to $3.0 million in 2023.
  • Business Quant data shows Interest & Investment Income for ALXO at $3.0 million in Q4 2023, $2.7 million in Q3 2023, and $2.7 million in Q2 2023.